{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:26:25Z","timestamp":1790713585415,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T00:00:00Z","timestamp":1297209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/npp.2011.6","type":"journal-article","created":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T10:01:02Z","timestamp":1297245662000},"page":"1219-1226","source":"Crossref","is-referenced-by-count":664,"title":["Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Na\u00efve Social Phobia Patients"],"prefix":"10.1038","volume":"36","author":[{"given":"Mateus M","family":"Bergamaschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Helena Costa","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Hortes Nisihara","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Chaves Gomes","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Spinosa","family":"De Martinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Roesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio E","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Mart\u00edn-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Eduardo Cec\u00edlio","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Waldo","family":"Zuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alexandre S","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,9]]},"reference":[{"key":"BFnpp20116_CR1","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/BF02085029","volume":"37","author":"S Agurell","year":"1981","unstructured":"Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L (1981). Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia 37: 1090\u20131092.","journal-title":"Experientia"},{"key":"BFnpp20116_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0031-6997(25)06861-9","volume":"38","author":"S Agurell","year":"1986","unstructured":"Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H et al (1986). Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38: 21\u201343.","journal-title":"Pharmacol Rev"},{"key":"BFnpp20116_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0006-3223(01)01294-X","volume":"51","author":"C Blanco","year":"2002","unstructured":"Blanco C, Antia SX, Liebowitz MR (2002). Pharmacotherapy of social anxiety disorder. Biol Psychiatry 51: 109\u2013120.","journal-title":"Biol Psychiatry"},{"key":"BFnpp20116_CR4","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","volume":"64","author":"SJ Borgwardt","year":"2008","unstructured":"Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, Seal ML et al (2008). Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry 64: 966\u2013973.","journal-title":"Biol Psychiatry"},{"key":"BFnpp20116_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0165-0327(99)00140-8","volume":"60","author":"N Brunello","year":"2000","unstructured":"Brunello N, den Boer JA, Judd LL, Kasper S, Kelsey JE, Lader M et al (2000). Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J Affect Disord 60: 61\u201374.","journal-title":"J Affect Disord"},{"key":"BFnpp20116_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jpsychires.2007.01.002","volume":"42","author":"JD Buckner","year":"2008","unstructured":"Buckner JD, Schmidt NB, Lang AR, Small JW, Schlauch RC, Lewinsohn PM (2008). Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res 42: 230\u2013239.","journal-title":"J Psychiatr Res"},{"key":"BFnpp20116_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","volume":"199","author":"AC Campos","year":"2008","unstructured":"Campos AC, Guimaraes FS (2008). Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology 199: 223\u2013230.","journal-title":"Psychopharmacology"},{"issue":"Suppl 2","key":"BFnpp20116_CR8","first-page":"9","volume":"51","author":"Canadian Psychiatric Association","year":"2006","unstructured":"Canadian Psychiatric Association (2006). Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatryi 51 (Suppl 2): 9\u201391.","journal-title":"Can J Psychiatryi"},{"key":"BFnpp20116_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1590\/S1516-44462010005000029","volume":"32","author":"MH Chagas","year":"2010","unstructured":"Chagas MH, Nardi AE, Manfro GG, Hetem LA, Andrada NC, Levitan MN et al (2010). Guidelines of the Brazilian medical Association for the diagnosis and differential diagnosis of social anxiety disorder. Rev Bras Psiquiatr 32: 444\u2013452.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFnpp20116_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1192\/bjp.176.4.379","volume":"176","author":"KM Connor","year":"2000","unstructured":"Connor KM, Davidson JR, Churchill LE, Sherwood A, Foa E, Weisler RH (2000). Psychometric properties of Social Phobia Inventory (SPIN). Br J Psychiatry 176: 379\u2013386.","journal-title":"Br J Psychiatry"},{"key":"BFnpp20116_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/da.1055","volume":"14","author":"KM Connor","year":"2001","unstructured":"Connor KM, Kobak KA, Churchill LE, Katzelnick D, Davidson JR (2001). Mini-Spin: a brief screening assessment for generalized social anxiety disorder. Depress Anxiety 14: 137\u2013140.","journal-title":"Depress Anxiety"},{"key":"BFnpp20116_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1744-6163.2008.00183.x","volume":"44","author":"JA Crippa","year":"2008","unstructured":"Crippa JA, de Lima Osrio F, Del-Ben CM, Filho AS, da Silva Freitas MC, Loureiro SR (2008a). Comparability between telephone and face-to-face structured clinical interview for DSM-IV in assessing social anxiety disorder. Perspect Psychiatr Care 44: 241\u2013247.","journal-title":"Perspect Psychiatr Care"},{"key":"BFnpp20116_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","volume":"25","author":"JA Crippa","year":"2011","unstructured":"Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran F, Marti N-Santos RO et al (2011). Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder\u2014a preliminary report. J Psychopharmacol 25: 121\u2013130.","journal-title":"J Psychopharmacol"},{"key":"BFnpp20116_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1590\/S1516-44462007000200027","volume":"29","author":"JA Crippa","year":"2007","unstructured":"Crippa JA, Loureiro SR, Baptista CA, Os\u00f3rio F (2007). Are there differences between early- and late-onset social anxiety disorder? Rev Bras Psiquiatr 29: 195\u2013196.","journal-title":"Rev Bras Psiquiatr"},{"issue":"Suppl 2","key":"BFnpp20116_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.eurpsy.2008.01.359","volume":"23","author":"JA Crippa","year":"2008","unstructured":"Crippa JA, Zuardi AW, Busatto GF, Santos-Filho A, Graeff FG, Borduqui T et al (2008b). Grey matter correlates of cognitive measures of the simulated public speaking test in social anxiety spectrum: a voxel-based study. Eur Psychiatry 23 (Suppl 2): 212.","journal-title":"Eur Psychiatry"},{"key":"BFnpp20116_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.npp.1300340","volume":"29","author":"JA Crippa","year":"2004","unstructured":"Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, Ferrari L et al (2004). Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology 29: 417\u2013426.","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"BFnpp20116_CR17","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1590\/S1516-44462010000500009","volume":"32","author":"JA Crippa","year":"2010","unstructured":"Crippa JA, Zuardi AW, Hallak JE (2010). Therapeutical use of the cannabinoids in psychiatry. Rev Bras Psiquiatr 32 (Suppl 1): S56\u2013S66.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFnpp20116_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hup.1048","volume":"24","author":"JA Crippa","year":"2009","unstructured":"Crippa JA, Zuardi AW, Mart\u00edn-Santos R, Bhattacharyya S, Atakan Z, McGuire P (2009). Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol 24: 515\u2013523.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp20116_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.eurpsy.2007.01.003","volume":"22","author":"F de Lima Os\u00f3rio","year":"2007","unstructured":"de Lima Os\u00f3rio F, Crippa JA, Loureiro SR (2007). A study of the discriminative validity of a screening tool (MINI-SPIN) for social anxiety disorder applied to Brazilian university students. Eur Psychiatry 22: 239\u2013243.","journal-title":"Eur Psychiatry"},{"key":"BFnpp20116_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1590\/S0101-60832008000600001","volume":"35","author":"F de Lima Os\u00f3rio","year":"2008","unstructured":"de Lima Os\u00f3rio F, Crippa JA, Loureiro SR (2008). Self statements during public speaking scale (SSPS): cross-cultural adaptation for Brazilian Portuguese and internal consistency. Rev Psiq Cl\u00edn 35: 207\u2013211.","journal-title":"Rev Psiq Cl\u00edn"},{"key":"BFnpp20116_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1590\/S1516-44462001000300008","volume":"23","author":"CM Del-Ben","year":"2001","unstructured":"Del-Ben CM, Vilela JAA, Crippa JAS, Hallak JEC, Labate CM, Zuardi AW (2001). Confiabilidade teste-reteste da Entrevista Cl\u00ednica Estruturada para o DSM-IV\u2014Vers\u00e3o Cl\u00ednica (SCID-CV) traduzida para o portugu\u00eas. Rev Bras Psiquiatr 23: 156\u2013159.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFnpp20116_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1600-0447.2009.01459.x","volume":"121","author":"AS Filho","year":"2010","unstructured":"Filho AS, Hetem LA, Ferrari MC, Trzesniak C, Mart\u00edn-Santos R, Borduqui T et al (2010). Social anxiety disorder: what are we losing with the current diagnostic criteria? Acta Psychiatr Scand 121: 216\u2013226.","journal-title":"Acta Psychiatr Scand"},{"key":"BFnpp20116_CR23","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Clinican Version (SCID-CV)","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Clinican Version (SCID-CV). American Psychiatric Press: Washington, DC, USA."},{"key":"BFnpp20116_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1017\/S1461145709990617","volume":"13","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S et al (2009a). Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol. Int J Neuropsychopharmacol 13: 421\u2013432.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp20116_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","volume":"66","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R et al (2009b). Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 66: 95\u2013105.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp20116_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1590\/S0100-879X2003000400003","volume":"36","author":"FG Graeff","year":"2003","unstructured":"Graeff FG, Parente A, Del-Ben CM, Guimar\u00e3es FS (2003). Pharmacology of human experimental anxiety. Braz J Med Biol Res 36: 421\u2013432.","journal-title":"Braz J Med Biol Res"},{"key":"BFnpp20116_CR27","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.neuropharm.2006.11.005","volume":"52","author":"K Hayakawa","year":"2007","unstructured":"Hayakawa K, Mishima K, Nozako M, Ogata A, Hazekawa M, Liu AX et al (2007). Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance. Neuropharmacology 52: 1079\u20131087.","journal-title":"Neuropharmacology"},{"key":"BFnpp20116_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1590\/S1516-44462010000100016","volume":"32","author":"JE Hallak","year":"2010","unstructured":"Hallak JE, Crippa JA, Quevedo J, Roesler R, Schr\u00f6der N, Nardi AE et al (2010). National science and technology institute for translational medicine (INCT-TM): advancing the field of translational medicine and mental health. Rev Bras Psiquiatr 32: 83\u201390.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFnpp20116_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0005-7894(00)80027-1","volume":"31","author":"SG Hoffmann","year":"2000","unstructured":"Hoffmann SG, Di Bartolo PM (2000). An instrument to assess self-statements during public speaking: scale development and preliminary psychometric properties. Behav Ther 31: 499\u2013515.","journal-title":"Behav Ther"},{"issue":"Suppl 2","key":"BFnpp20116_CR30","first-page":"10","volume":"68","author":"RC Kessler","year":"2007","unstructured":"Kessler RC (2007). The global burden of anxiety and mood disorders: putting the European Study of the Epidemiology of Mental Disorders (ESEMeD) findings into perspective. J Clin Psychiatry 68 (Suppl 2): 10\u201319.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp20116_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF00436092","volume":"77","author":"DM McNair","year":"1982","unstructured":"McNair DM, Frankenthaler LM, Czerlinsky T, White TW, Sasson S, Fisher S (1982). Simulated public speaking as a model of clinical anxiety. Psychopharmacology (Berl) 77: 7\u201310.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp20116_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.euroneuro.2004.06.001","volume":"14","author":"SA Montgomery","year":"2004","unstructured":"Montgomery SA, Lecrubier Y, Baldwin DS, Kasper S, Lader M, Nil R et al (2004). European college of neuropsychopharmacology. ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder. Eur Neuropsychopharmacol 14: 425\u2013433.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp20116_CR33","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/npp.2010.58","volume":"35","author":"CJ Morgan","year":"2010","unstructured":"Morgan CJ, Freeman TP, Schafer GL, Curran HV (2010). Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology 35: 1879\u20131885.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp20116_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0028-3908(71)90039-6","volume":"10","author":"H Norris","year":"1971","unstructured":"Norris H (1971). The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 10: 181\u2013191.","journal-title":"Neuropharmacology"},{"key":"BFnpp20116_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1744-6163.2010.00261.x","volume":"46","author":"L Os\u00f3rio Fde","year":"2010","unstructured":"Os\u00f3rio Fde L, Crippa JA, Loureiro SR (2010). Further study of the psychometric qualities of a brief screening tool for social phobia (MINI-SPIN) applied to clinical and nonclinical samples. Perspect Psychiatr Care 46: 266\u2013278.","journal-title":"Perspect Psychiatr Care"},{"key":"BFnpp20116_CR36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.euroneuro.2005.05.002","volume":"15","author":"ACBV Parente","year":"2005","unstructured":"Parente ACBV, Garcia-Leal C, Del-Ben C, Guimar\u00e3es FS, Graeff FG (2005). Subjective and neurovegetative changes in health volunteers and panic patients performing simulated public speaking. Eur Neuropsychopharmacol 15: 663\u2013671.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp20116_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","volume":"175","author":"LA Parker","year":"2004","unstructured":"Parker LA, Burton P, Sorge RE, Yakiwchuk C, Mechoulam R (2004). Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology (Berl) 175: 360\u2013366.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp20116_CR38","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","volume":"29","author":"Y Ren","year":"2009","unstructured":"Ren Y, Whittard J, Higuera-Matas A, Morris CV, Hurd YL (2009). Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci 29: 14764\u201314769.","journal-title":"J Neurosci"},{"key":"BFnpp20116_CR39","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","volume":"30","author":"EB Russo","year":"2005","unstructured":"Russo EB, Burnett A, Hall B, Parker KK (2005). Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30: 1037\u20131043.","journal-title":"Neurochem Res"},{"issue":"Suppl 1","key":"BFnpp20116_CR40","first-page":"43","volume":"62","author":"FR Schneier","year":"2001","unstructured":"Schneier FR (2001). Treatment of social phobia with antidepressants. J Clin Psychiatry 62 (Suppl 1): 43\u201348.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp20116_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","volume":"213","author":"VDEP Soares","year":"2010","unstructured":"Soares VDEP, Campos AC, Bortoli VC, Zangrossi Jr H, Guimar\u00e3es FS, Zuardi AW (2010). Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. Behav Brain Res 213: 225\u2013229.","journal-title":"Behav Brain Res"},{"key":"BFnpp20116_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","volume":"30","author":"AW Zuardi","year":"2008","unstructured":"Zuardi AW (2008). Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr 30: 271\u2013280.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFnpp20116_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/026988119300700112","volume":"7","author":"AW Zuardi","year":"1993","unstructured":"Zuardi AW, Cosme RA, Graeff FG, Guimar\u00e3es FS (1993). Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol 7: 82\u201388.","journal-title":"J Psychopharmacol"},{"key":"BFnpp20116_CR44","first-page":"403","volume":"131","author":"AW Zuardi","year":"1981","unstructured":"Zuardi AW, Karniol IG (1981). Transcultural evaluation of a self-evaluation scale of subjective states. J Brasileiro Psiquiatr 131: 403\u2013406.","journal-title":"J Brasileiro Psiquiatr"},{"key":"BFnpp20116_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF00432554","volume":"76","author":"AW Zuardi","year":"1982","unstructured":"Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982). Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology (Berl) 76: 245\u2013250.","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp20116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp20116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp20116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T08:26:46Z","timestamp":1740904006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp20116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["BFnpp20116"],"URL":"https:\/\/doi.org\/10.1038\/npp.2011.6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.720452506.793545378","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,9]]}}}